ArticleInvestigational new drugs2020

A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors.

Markus Joerger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.